ALAMEDA, CA – October 20, 2016 – AllCells, LLC announced today that Rob Frankenberg, Ph.D. has joined the company’s leadership team as Vice President, Manufacturing Operations.
Previously, Dr. Frankenberg held senior operations management positions at Bio-Rad Laboratories where he served as GMP Operations Manager having responsibility for operational leadership of Bio-Rad’s Northern California GMP clinical diagnostics consumables manufacturing operation, and Manager of Production, Engineering, Maintenance, and Documentation, overseeing Bulk Chemical Production operations. Prior to Bio-Rad Dr. Frankenberg served in various executive manufacturing and project management roles with Novartis Pharmaceutical Division, and Bayer Healthcare.
“With more than 25 years experience in life science and biopharmaceutical industries, Dr. Frankenberg brings to AllCells a strong combination of supply-chain, manufacturing, and inventory management skill sets that will enable our continued growth while simultaneously enhancing operational efficiencies such that we continue to deliver optimal value to our customers,” commented Jay Tong, M.D, President & CEO of AllCells. “Rob will provide leadership in facilitating some of our company’s most important strategic initiatives such as completing operational readiness of our new US east-coast based clinical tissue collection facilities, expected to go live November, 2016 (“AllCells-Boston, MA”), and implementation of a new best in class ERP system in 2017.”
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (“Bioservices”) custom designed according to customer criteria. For more information, please visit www.allcells.com.
Wayne E. Vaz